Colin Lightfoot

B.Sc. Biomedical Science, M.Sc. Infection and Immunity

Colin graduated from the University of Chester with a B.Sc. in Biomedical Science in 2020. Since completing his undergraduate degree, he worked for NHS England as an Associate Practitioner, responsible for testing inpatients for COVID-19 on admission.

Recently Colin was a Study Assistant for Perfectus Biomed, where he grew cell lines and viruses for the testing of mainly commercial cleaning products. He recently completed an M.Sc. in Infection and Immunity at The University of Chester, where his main research focus was antibiotic resistance and the possibility of combatting this with bacteriophage therapy.

See less

Colin Lightfoot

Articles from Colin

γ’ fibrinogen as a disease progression marker for COVID-19

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

Investigating Omicron’s fitness and replicative potential compared with earlier SARS-CoV-2 variants using organoids

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

Echinacea as a potential force against coronavirus infections

Alphacoronaviruses found to be common in bats in the upper Midwestern United States

SARS-CoV-2 prevalence in bivalve mollusks from harvesting areas in Southern Italy

Relationship between SARS-CoV-2 infection rates and government-implemented stringency measures in Africa

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News